Following U.S. Stocks were among the “Top Losers” during Monday’s trade: Midway Gold Corp (USA) (NYSEMKT:MDW), Unilife Corp (NASDAQ:UNIS), Key Energy Services, Inc (NYSE:KEG), Rowan Companies PLC (NYSE:RDC)

Their insights are depicted underneath:

Midway Gold Corp (USA) (NYSEMKT:MDW)’s shares dwindled -5.36%, and closed at $0.530, hitting new 52-week low of $0.52.

Through BUSINESS WIRE, Midway Gold Corp. (MDW), released that construction of the Pan Gold Mine (“Pan”) in Nevada is about 93% complete and first gold production is predictable by the end of March.

Recent Pan Project Milestones:

On February 7, after six days of irrigation, initial breakthrough of fresh water that had been cycled through the pad was realized. As of the end of February, 3.1 million tons of ore have been placed on the heap leach pad. 2.0 million tons of ore are presently being irrigated with solution flows to the leach pad at about 14% of capacity, as the system ramps up to the design of 5,000 gallons per minute.

Midway Gold Corp. is a precious metals corporation with a vision to explore, design, build and operate gold mines in a manner accountable to all stakeholders while seeking returns for shareholders.

Unilife Corp (NASDAQ:UNIS), declined -5.33%, and closed at $3.73.

Through PRNewswire, Unilife Corporation (UNIS), a developer and supplier of injectable drug delivery systems, recently declared its financial results for the quarter ended December 31, 2014.

Recent Financial Highlights:

• $7.3 million in cash receipts from customers in 2Q FY15
• Quarterly proceed of $5.4 million, up 50% contrast to preceding year quarter
• Deferred proceed of $17.1 million as of the end of 2Q FY15
• Accomplished a U.S. public offering of ordinary stock, bringing net proceeds to Unilife of $44.7 million in February 2015.

Business Highlights:

• In October 2014, Unilife declared a worldwide Master Services and Commercial Supply Contract with Sanofi to be the sole provider of cartridge-based wearable injectors for all of Sanofi’s applicable large-dose volume drugs, not including insulins, for a minimum of 15 years. Additionally, the contract will allow Sanofi to make Unilife’s wearable injectors accessible to its partners for use with applicable molecules under joint collaborations.
• In November 2014, Unilife signed a Global Planned Alliance Contract with Flextronics, a leader in end-to-end supply chain solutions, as its global planned partner to further expand the production capacity and scale-up capability of Unilife’s product portfolio.
• In December 2014, Unilife signed a worldwide 10 year Commercial Supply Contract with a global pharmaceutical customer for the use of the Depot-ject™ delivery system with an ocular injection therapy approved in the U.S. and Europe for the treatment of a high-prevalence disease of the retina.
• In January 2015, Unilife declared that David Hastings will join the Corporation on February 23, 2015, as Chief Financial Officer. Mr. Hastings most recently served as Chief Financial Officer at Incyte Corporation from 2003 to 2014.
• On January 20, 2015, Unilife filed a Form 8-K regardinga definitive global planned contract with a global biopharmaceutical corporation for the customization and supply of its injectable drug delivery systems for use with the customer’s drug portfolio. The customer will pay $5 million for the exclusive right to form and enter into a mutually agreeable development and supply contract with Unilife to comprise exclusive access to the Unifill Finesse™ prefilled syringe and the LISA™ reusable auto-injector for target therapies within the customer’s drug portfolio for the treatment of autoimmune diseases, in addition to associated exclusivity fees.

Unilife Corporation (NASDAQ:UNIS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife’s broad portfolio of proprietary technologies comprises prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and novel systems.

Key Energy Services, Inc (NYSE:KEG), dipped -5.32%, and closed at $1.78.

Through PRNewswire, on February 18, Key Energy Services Inc. (KEG), stated fourth quarter 2014 merged proceeds of $354.8 million and a pre-tax GAAP loss of $80.8 million, or $0.34 per share. The results for the fourth quarter comprise a pre-tax charge of $31.7 million, or $0.13 per share, for a true-up to the impairment charge of the Corporation’s U.S. assets taken in the third quarter and an additional impairment of the Corporation’s goodwill in the fourth quarter, pre-tax costs of $19.6 million, or $0.08 per share, related to the formerly revealed Foreign Corrupt Practices Act (“FCPA”) investigations and a pre-tax loss of $3.7 million, or $0.02 per share, on the disposal of obsolete assets. Not including these items, the Corporation stated a pre-tax loss of $24.7 million, or $0.10 per share. Third quarter 2014 merged proceeds were $365.8 million with a pre-tax GAAP loss of $97.0 million, or $0.41 per share. The results for the third quarter comprised of a pre-tax charge of $60.8 million, or $0.25 per share, for an impairment of the Corporation’s U.S. assets and pre-tax costs of $16.1 million, or $0.07 per share, related to the FCPA investigations. Not including these two items, in the third quarter the Corporation stated a pre-tax loss of $20.1 million, or $0.08 per share.

For the full-year 2014, merged proceeds were $1.43 billion, down 10.3% contrast to $1.59 billion for the full-year 2013. Full-year 2014 GAAP net loss was $178.6 million, or $1.16 per share, contrast to full-year 2013 GAAP net loss of $21.8 million, or $0.14 per share.

Key Energy Services is the largest onshore, rig-based well servicing contractor based on the number of rigs owned. Key provides a complete range of well intervention services and has operations in all major onshore oil and gas producing regions of the continental United States and internationally in Mexico, Colombia, Ecuador, the Middle East and Russia.

Rowan Companies PLC (NYSE:RDC), dropped -5.24%, and closed at $18.81, hitting new 52-week low of $18.78.

Through PRNewswire, on February 27, Rowan Companies plc (RDC), stated a net loss of $326.9 million, or $2.63 per share. The current quarter comprises a noncash asset impairment charge of $438.4 million (after tax), or $3.53 per share, regarding twelve of the Corporation’s oldest jack-up rigs. Not including the influence of this noncash asset impairment charge, net revenue was $111.5 million or $0.89 per share in the fourth quarter of 2014. Net revenue for the preceding-year quarter was $49.7 million or $0.40 per share and comprised of a noncash asset impairment charge of $2.9 million (after tax), or $0.02 per share. Not including the influence of the noncash asset impairment charge, net revenue was $52.6 million or $0.42 per share in the fourth quarter of 2013.

Rowan’s proceeds were $556.2 million in the fourth quarter of 2014, up 41% over the preceding-year quarter due primarily to the commencement of two of the corporation’s newbuild ultra-deepwater drillships, less out-of-service time for jack-up rigs and slightly higher average day rates.

Rowan Companies plc provides offshore oil and gas contract drilling services. It operates a fleet of 30 self-elevating mobile offshore jack-up drilling units, in addition to 3 ultra-deepwater drill ships.